Session: The Coming Transformation of Engagement
“Engagement” is top of mind for leaders in organizations across industries. From customer engagement to employment engagement to partner engagement, student engagement and patient engagement, organizations see the need for better, more predictable engagement as the key to their ongoing success and growth.
Unfortunately, true engagement – in the sense of meaningful interactions between organizations and those they serve that lead to deeper relationships and better outcomes – is increasingly difficult to pull off. The number of engagement channels continues to proliferate. We lack a comprehensive understanding of how people actually use various channels. Predicting the content, offers and messages that will effectively engage people involves a lot of guesswork.
And on top of it all, trust in organizations is at an all time low.
The good news is: All of this is about to change. With the right technical infrastructure, access to relevant data, and innovative applications of AI, we are about to enter an era where organizations can and will engage with people in ways that are relevant, respectful (particularly with regard to data privacy), predictable, and valuable.
- After this talk, the audience will understand: The key attributes of effective engagement
- After this talk, the audience will understand: The most significant obstacles to engagement today
- After this talk, the audience will understand: How AI, fueled by the right data, will overcome these obstacles
- After this talk, the audience will understand: How organizations can lay the foundation for the future of engagement today
Dr. Alice Jacobs leads the Convergence Group. The Group’s work on improving access to and delivery of healthcare through digital acceleration has led to the launch, in stealth mode, of an engagement AI platform aimed at influencing behavior through hyper-personalizing how we engage with consumers/patients. Dr. Jacobs has long focused on the intersection of science, healthcare, and business. As a student at Harvard Medical School, she founded her first company, IntelligentMDx after losing a patient from a staph infection. Since exiting IntelligentMDx, she has worked with leading venture funds including Third Rock Ventures/MIT/Bob Langer, GE Ventures and GreyBird Ventures. In this role, she helps companies commercialize life-changing technologies in healthcare and beyond. She spent two years as Entrepreneur-in-Residence at Caltech, guiding Nobel Laureates, National Academy members and pioneering data scientists. Dr. Jacobs holds multiple patents in personalized medicine and rapid diagnostic testing. She has been recognized by Scientific American as one of the top 50 innovators in science and technology and selected by the World Economic Forum as a member of the Young Global Leaders.